Get the Stockscreener App
81.13
1.54%
-1.27
Pre-market:
85.43
4.30
+5.30%
Mesa Laboratories Inc stock is traded at $81.13, with a volume of 99,074.
It is down -1.54% in the last 24 hours and down -14.82% over the past month.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
See More
Previous Close:
$82.40
Open:
$80.3
24h Volume:
99,074
Relative Volume:
0.92
Market Cap:
$448.23M
Revenue:
$247.54M
Net Income/Loss:
$3.73M
P/E Ratio:
125.67
EPS:
0.6456
Net Cash Flow:
$37.69M
1W Performance:
-0.69%
1M Performance:
-14.82%
6M Performance:
+22.17%
1Y Performance:
-36.84%
1-Day Range:
$79.38
$82.50
1-Week Range:
$79.38
$84.65
52-Week Range:
$55.45
$131.20
Mesa Laboratories Inc Stock (MLAB) Company Profile
Name
Mesa Laboratories Inc
Sector
Phone
(303) 987-8000
Address
12100 W 6TH AVE, LAKEWOOD
Compare MLAB vs KEYS, COHR, GRMN, TDY, FTV
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MLAB
Mesa Laboratories Inc
|
81.13 | 448.23M | 247.54M | 3.73M | 37.69M | 0.6456 |
KEYS
Keysight Technologies Inc
|
298.58 | 51.21B | 5.68B | 981.00M | 1.33B | 5.5376 |
COHR
Coherent Corp
|
272.33 | 51.06B | 6.29B | 272.68M | -103.62M | 1.0105 |
GRMN
Garmin Ltd
|
241.11 | 46.41B | 7.25B | 1.66B | 1.36B | 8.5936 |
TDY
Teledyne Technologies Inc
|
626.06 | 29.00B | 6.12B | 895.70M | 1.07B | 18.90 |
FTV
Fortive Corp
|
54.90 | 16.90B | 5.14B | 647.00M | 978.10M | 1.7328 |
Mesa Laboratories Inc Stock (MLAB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-07-25 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Aug-28-24 | Initiated | Wells Fargo | Underweight |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Jan-04-21 | Downgrade | Evercore ISI | Outperform → In-line |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-02-20 | Initiated | JP Morgan | Neutral |
| Dec-04-19 | Initiated | Jefferies | Buy |
| Aug-26-19 | Initiated | Evercore ISI | Outperform |
| Jun-10-16 | Downgrade | Sidoti | Buy → Neutral |
View All
Mesa Laboratories Inc Stock (MLAB) Latest News
Mesa Laboratories (NASDAQ:MLAB) Stock Price Passes Above 200-Day Moving Average – Here’s What Happened - Defense World
Mesa Laboratories Announces CEO Transition and Details Retention and Transition Agreement for Gary M. Owens - Minichart
Mesa Laboratories announces CEO transition and board resignation - Investing.com
Mesa Laboratories CEO Gary Owens Announces Planned Departure - TipRanks
Mesa Laboratories (NASDAQ: MLAB) sets CEO Owens transition and board exit - Stock Titan
Portfolio Shifts: How does Mesa Laboratories Inc score in quality rankingsMarket Risk Analysis & Fast Entry High Yield Tips - baoquankhu1.vn
Published on: 2026-03-20 18:41:56 - baoquankhu1.vn
Aug Swings: What is the cash position of Mesa Laboratories Inc2026 Price Targets & Scalable Portfolio Growth Methods - baoquankhu1.vn
Street Watch: Is Mesa Laboratories Inc a speculative investmentQuarterly Risk Review & Verified Momentum Stock Alerts - baoquankhu1.vn
Mason Capital Management LLC Invests $4.71 Million in Mesa Laboratories, Inc. $MLAB - MarketBeat
RSI Check: Can Mesa Laboratories Inc sustain earnings growthWeekly Stock Summary & Precise Entry and Exit Recommendations - baoquankhu1.vn
Mesa Laboratories, Inc. $MLAB Shares Bought by Crawford Investment Counsel Inc. - MarketBeat
Mesa Labs names Dr. Siddhartha Kadia as new CEO - Investing.com Nigeria
Simcoe Capital Management LLC Makes New Investment in Mesa Laboratories, Inc. $MLAB - MarketBeat
Long Path (MLAB) reports 311,703 shares, 5.6% ownership stake - Stock Titan
Tuesday’s insider activity: Major buys at PROCEPT and Mesa Labs - Investing.com
Market Wrap: What are analysts price targets for Mesa Laboratories IncChart Signals & Free Reliable Trade Execution Plans - baoquankhu1.vn
Gabelli Funds LLC Grows Stake in Mesa Laboratories, Inc. $MLAB - MarketBeat
Insider Buying: Mark Capone Acquires Shares of Mesa Laboratories Inc (MLAB) - GuruFocus
Mesa Laboratories CEO Transition and Earnings Beat Expectations - Intellectia AI
Capone Mark Christopher buys Mesa Laboratories shares for $99,331 - Investing.com Australia
Insider Buying: Mesa Laboratories (NASDAQ:MLAB) Director Buys 3,500 Shares of Stock - MarketBeat
Insider Buying: R Tripeny Acquires Shares of Mesa Laboratories I - GuruFocus
Mesa Laboratories: Hard To Set The Right Diagnosis (NASDAQ:MLAB) - Seeking Alpha
[Form 4] MESA LABORATORIES INC /CO/ Insider Trading Activity - Stock Titan
Tripeny R Tony, director, buys $99k in Mesa Laboratories (MLAB) - Investing.com Nigeria
Mesa Laboratories (NASDAQ:MLAB) Director Acquires $99,940.00 in Stock - MarketBeat
Mark Christopher Capone Acquires 1,301 Shares of Mesa Laboratories (NASDAQ:MLAB) Stock - MarketBeat
Mesa Laboratories (MLAB) director buys 1,301 shares in open-market trade - Stock Titan
Director buys Mesa Laboratories (MLAB) stock in open-market trade - Stock Titan
Mesa Laboratories Appoints Siddhartha Kadia as New President and CEO Effective April 2026 - Minichart
Mesa Labs names Dr. Siddhartha Kadia as new CEO By Investing.com - Investing.com Canada
Mesa Laboratories names new CEO - MSN
Mesa Laboratories announces CEO transition and appointment of Siddhartha Kadia as president and CEO - marketscreener.com
Mesa Laboratories Names New CEO for Next Phase - TipRanks
Mesa Laboratories Announces CEO Transition And Appointment Of Siddhartha Kadia As President And CEO - TradingView
Mesa Laboratories (NASDAQ: MLAB) taps Siddhartha Kadia to succeed CEO Gary Owens - Stock Titan
Mesa Laboratories Announces CEO Transition and Appointment of Siddhartha Kadia as President and CEO - Bitget
Trading Systems Reacting to (MLAB) Volatility - Stock Traders Daily
Swing Trade: How sensitive is MANH to inflation2026 Volume Leaders & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Trading Action: Is Horizon Bancorp Incs ROIC above industry averageQuarterly Investment Review & Comprehensive Market Scan Reports - baoquankhu1.vn
Royce & Associates LP Sells 99,048 Shares of Mesa Laboratories, Inc. $MLAB - MarketBeat
MLAB Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Sell Signal: Is Mesa Laboratories Inc a speculative investmentCPI Data & Daily Risk Controlled Trade Plans - baoquankhu1.vn
76,657 Shares in Mesa Laboratories, Inc. $MLAB Acquired by Roubaix Capital LLC - MarketBeat
Mesa Laboratories (NASDAQ:MLAB) Stock Price Crosses Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
What are Mesa Laboratories Inc.’s earnings expectations2025 Macro Impact & Low Volatility Stock Recommendations - mfd.ru
Here's Why Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) - Finviz
Here’s Why Conestoga Capital Advisors Sold Mesa Laboratories (MLAB) - Insider Monkey
Principal Financial Group Inc. Decreases Stock Holdings in Mesa Laboratories, Inc. $MLAB - MarketBeat
As worker safety scrutiny intensifies, Mesa Labs reinforces why primary standard calibration is the only line of defense - News-Medical
Mesa Laboratories Inc Stock (MLAB) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.00%
2.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):